Press Releases
SINGAPORE, Aug. 1, 2019 /PRNewswire/ -- On July 29, 2019, at the invitation of Dalian Municipal People's Government, Mr. Frank Wang, Chairman of Biosyngen Group and Dr. Victor Li, CEO of Biosyngen Group attended the 10th Singapore-Liaoning Economic and Trade Council (SLETC) meeti
Read more...The newest osmometer designed to meet complex bioprocessing needs NORWOOD, Mass., Aug. 1, 2019 /PRNewswire/ -- Advanced Instruments—an innovative developer of scientific and analytical instruments and related services for the biotech industry—announced the latest release to its biotech instrument portfolio, the OsmoTECH PRO Multi-Sample M
Read more...1 August 2019
VAUGHAN, ON, Aug. 1, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today announced that it will likely miss its filing deadline (the "Filing Deadline") of August 14, 2019 to file an interim financial report for the three and six month periods ended June 30, 2019
Read more...1 August 2019
TAMPA, Fla., Aug. 1, 2019 /PRNewswire/ -- Savii, Inc., is pleased to announce the addition of
Read more...1 August 2019
LARNACA, Cyprus, Aug. 1, 2019 /PRNewswire/ -- AXON NEUROSCIENCE SE, a global leader in the development of tau-immunotherapies and diagnostics for Alzheimer's disease and other tauopathies, today announces the appointment of Michal Fresser as Chief Executive Officer of Axon Group. Mr Fresser, who currently serves as General Counsel, will also be appointed as Chairman of
Read more...FRANKLIN, Tenn., Aug. 1, 2019 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended June 30, 2019. This dividend, in the amount of $0.4125 per share, is payable on
Read more...ARLINGTON, Va., Aug. 1, 2019 /PRNewswire/ -- Tantus Technologies, Inc. (Tantus) today announced its latest contract award at the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Financial Resources (ASFR). This contract is a recompete of Tantus' existing work supporting enterprise-wide financial systems and operations at HHS.
Read more...NEWARK, Calif., Aug. 1, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced results from the completed Phase 1 normal healthy volunteer (NHV) study of PN-943, an oral, gut-restricted alpha-4-beta-7 integrin specific antagonist in development for the potential treatment of inflammatory bowel disease (IBD). Results of the first clinical
Read more...1 August 2019
MECHANICSBURG, Pa., Aug. 1, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced results for its second quarter ended June 30, 2019.For the second quarter ended June 30, 2019, net operating revenues increased 5.0% to $1,361.4 million, compared to
Read more...NASDAQ: CORV TSX: CORV VANCOUVER, Aug. 1, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has undertaken an overnight marketed underwritten public offering (the "Offering") of its common shares. In addition, Correvio expe
Read more...